ArticleJournal of thoracic disease2025
The global status and trends of local ablation for lung malignancies: a bibliometric and visualization analysis.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Electrodes of radiofrequency ablation for malignant lung tumors: a narrative review of advances, applications, and prospects.Journal of thoracic disease · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer remains the leading cause of cancer-related mortality globally. In recent years, the advent of image-guided percutaneous ablation techniques has led to a gradual increase in the application of local ablation therapy (LAT) for both primary and secondary lung malignancies. Despite this progress, a systematic summary of the research trends and current clinical applications in this field is still lacking. Bibliometric analysis, a powerful statistical and visualization tool, can provide valuable insights into the evolving landscape of this therapeutic modality. This study aimed to examine the utilization of LAT for both primary and metastatic lung cancers, while exploring current research focuses and potential future directions in this field. Methods: By leveraging the Web of Science (WOS) core collection database, this study employed VOSviewer and bibliometrix tools to analyze current research trends and future development directions of LAT for both primary and metastatic lung cancers. Results: The study findings revealed a steady increase in annual publication volume between 2008 and 2023. Research output was predominantly contributed by China, the United States, and Japan. Among institutions, Memorial Sloan Kettering Cancer Center led in publication count, with Shandong University and Okayama University following closely. The Conclusions: Local ablation combined with other treatments are expected to improve therapeutic effects and become future trend in the treatment of lung malignancies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.